Analyst Price Targets — APYX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 13, 2026 10:02 am | Yi Chen | H.C. Wainwright | $7.00 | $4.38 | TheFly | Apyx Medical initiated with a Buy at H.C. Wainwright |
| March 11, 2026 1:12 pm | — | Craig-Hallum | $6.00 | $3.93 | TheFly | Apyx Medical price target raised to $6 from $5 at Craig-Hallum |
| December 15, 2025 9:05 pm | — | Roth Capital | $6.00 | $3.82 | TheFly | Apyx Medical initiated with a Buy at Roth Capital |
| December 8, 2022 9:02 am | — | Lake Street | $5.00 | $1.85 | Benzinga | Lake Street Assumes Apyx Medical at Buy, Announces Price Target of $5 |
| August 11, 2022 8:54 pm | Matt O'Brien | Piper Sandler | $12.00 | $10.28 | TheFly | Apyx Medical price target raised to $12 from $6 at Piper Sandler |
| July 19, 2022 10:29 am | — | Lake Street | $17.00 | $8.44 | Benzinga | Lake Street Maintains Buy on Apyx Medical, Raises Price Target to $17 |
Latest News for APYX
CLEARWATER, Fla., May 27, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations.
Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach
CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the publication of a new retrospective investigator-initiated study in Plastic and Reconstructive Surgery - Global Open 1.
Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for APYX.
U.S. House Trading
No House trades found for APYX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.